OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making
Carlos J. Pirola, Silvia Sookoian
Expert Review of Gastroenterology & Hepatology (2023) Vol. 17, Iss. 4, pp. 317-324
Closed Access | Times Cited: 7
Carlos J. Pirola, Silvia Sookoian
Expert Review of Gastroenterology & Hepatology (2023) Vol. 17, Iss. 4, pp. 317-324
Closed Access | Times Cited: 7
Showing 7 citing articles:
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Luis Antonio Díaz, Juan Pablo Arab, Alexandre Louvet, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 764-783
Closed Access | Times Cited: 96
Luis Antonio Díaz, Juan Pablo Arab, Alexandre Louvet, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 764-783
Closed Access | Times Cited: 96
From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease
Mary E. Rinella, Silvia Sookoian
Journal of Lipid Research (2023) Vol. 65, Iss. 1, pp. 100485-100485
Open Access | Times Cited: 74
Mary E. Rinella, Silvia Sookoian
Journal of Lipid Research (2023) Vol. 65, Iss. 1, pp. 100485-100485
Open Access | Times Cited: 74
Genetics of MASLD: The State of Art Update.
Silvia Sookoian, Yaron Rotman, Luca Valenti
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 11, pp. 2177-2187.e3
Closed Access | Times Cited: 15
Silvia Sookoian, Yaron Rotman, Luca Valenti
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 11, pp. 2177-2187.e3
Closed Access | Times Cited: 15
Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review
Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 9
Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 9
Organ damage proteomic signature identifies patients with MASLD at-risk of systemic complications.
Carlos J. Pirola, Luis Diambra, Tomas Fernández Gianotti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Carlos J. Pirola, Luis Diambra, Tomas Fernández Gianotti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Editorial: NAFLD , chronic kidney disease, and pleiotropy—Why is PNPLA3 omnipresent?
Carlos J. Pirola, Silvia Sookoian
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 10, pp. 1180-1182
Open Access | Times Cited: 2
Carlos J. Pirola, Silvia Sookoian
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 10, pp. 1180-1182
Open Access | Times Cited: 2
Interleukin-mediated therapies in liver diseases and comorbidity effects
Nouhoum Bouare, Jean Delwaide
World Journal of Hepatology (2024) Vol. 16, Iss. 7, pp. 980-989
Open Access
Nouhoum Bouare, Jean Delwaide
World Journal of Hepatology (2024) Vol. 16, Iss. 7, pp. 980-989
Open Access
